How to buy Schrödinger stock - 13 April

Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy Schrödinger stock

Own Schrödinger stock in just a few minutes.

Schrödinger, Inc is a health information services business based in the US. Schrödinger shares (SDGR) are listed on the NASDAQ and all prices are listed in US Dollars. Schrödinger employs 445 staff and has a trailing 12-month revenue of around USD$108.1 million.

How to buy shares in Schrödinger

  1. Compare share trading platforms. If you're a beginner, look for a platform with low commissions, expert ratings and investment tools to track your portfolio. Narrow down top brands with our comparison table.
  2. Open and fund your brokerage account. Complete an application with your personal and financial details, like your ID and bank information. Fund your account with a bank transfer, credit card or debit card.
  3. Search for Schrödinger. Find the stock by name or ticker symbol: SDGR. Research its history to confirm it's a solid investment against your financial goals.
  4. Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Schrödinger reaches your desired price. To spread out your purchase, look into dollar-cost averaging, which smooths out buying at consistent intervals and amounts.
  5. Decide on how many to buy. Weigh your budget against a diversified portfolio that can minimize risk through the market's ups and downs. You may be able to buy a fractional share of Schrödinger, depending on your broker.
  6. Check in on your investment. Congratulations, you own a part of Schrödinger. Optimize your portfolio by tracking how your stock — and even the business — performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that can affect your stock.

Schrödinger share price

Use our graph to track the performance of SDGR stocks over time.

Schrödinger shares at a glance

Information last updated 2021-04-09.
52-week rangeUSD$35.8 - USD$117
50-day moving average USD$84.1856
200-day moving average USD$74.5561
Wall St. target priceUSD$92.75
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) USD$-0.3999

Buy Schrödinger shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
Name Product Stock trade fee Asset types Option trade fee Annual fee Signup bonus
Sofi Invest
Stocks, ETFs, Cryptocurrency
A free way to invest in stocks, ETFs and crypto.
Stocks, Options, ETFs, Gold/Commodities
Free stock (chosen randomly with a value anywhere between $2.50 and $200)
Sign up using the "go to site" link
Make unlimited commission-free trades in stocks, funds, and options with Robinhood Financial.
Interactive Brokers
Stocks, Bonds, Options, Mutual funds, ETFs
$0 + $0.65/contract, $1 minimum
IBKR Lite offers $0 commissions, and IBKR Pro offers advanced tools for professional traders.
Stocks, Options, ETFs
Get one free stock valued between $2.50 and $250 when you open an account, one more with a deposit
Open an account
Margin financing rates start at 3.99%. No monthly subscription fees for margin.
Stocks, ETFs
$0 per month

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Schrödinger stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Schrödinger financials

Revenue TTM USD$108.1 million
Gross profit TTM USD$63.5 million
Return on assets TTM -8.45%
Return on equity TTM -7.38%
Profit margin -22.63%
Book value N/A
Market capitalisation USD$5.4 billion

TTM: trailing 12 months

Shorting Schrödinger shares

There are currently 3.9 million Schrödinger shares held short by investors – that's known as Schrödinger's "short interest". This figure is 33% up from 2.9 million last month.

There are a few different ways that this level of interest in shorting Schrödinger shares can be evaluated.

Schrödinger's "short interest ratio" (SIR)

Schrödinger's "short interest ratio" (SIR) is the quantity of Schrödinger shares currently shorted divided by the average quantity of Schrödinger shares traded daily (recently around 1.9 million). Schrödinger's SIR currently stands at 2.02. In other words for every 100,000 Schrödinger shares traded daily on the market, roughly 2020 shares are currently held short.

However Schrödinger's short interest can also be evaluated against the total number of Schrödinger shares, or, against the total number of tradable Schrödinger shares (the shares that aren't held by "insiders" or major long-term shareholders – also known as the "float"). In this case Schrödinger's short interest could be expressed as 0.06% of the outstanding shares (for every 100,000 Schrödinger shares in existence, roughly 60 shares are currently held short) or 0.1114% of the tradable shares (for every 100,000 tradable Schrödinger shares, roughly 111 shares are currently held short).

Such a low SIR usually points to an optimistic outlook for the share price, with fewer people currently willing to bet against Schrödinger.

Find out more about how you can short Schrödinger stock.

Schrödinger share dividends

We're not expecting Schrödinger to pay a dividend over the next 12 months.

Schrödinger overview

Schrödinger, Inc. provides physics-based software platform that enables discovery of novel molecules for drug development and materials applications. The company operates through two segments, Software and Drug Discovery. The Software segment is focused on selling its software for drug discovery in the life sciences industry, as well as to customers in materials science industries. The Drug Discovery segment focuses on building a portfolio of preclinical and clinical programs, internally and through collaborations. The company serves biopharmaceutical and industrial companies, academic institutions, and government laboratories worldwide. Schrödinger, Inc. has strategic collaborations with Thermo Fisher Scientific to extend the use of cryo-EM in connection within silico compound screening to accelerate drug discovery; and Bristol Myers Squibb Company to discover, develop, and commercialize therapeutics in multiple disease areas. The company was incorporated in 1990 and is headquartered in New York, New York.

Frequently asked questions

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site